VANGUARD GROUP INC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$217,620,000
+4.3%
1,439,571
+0.5%
0.01%0.0%
Q2 2022$208,723,000
+23.8%
1,432,458
+0.8%
0.01%
+50.0%
Q1 2022$168,573,000
-10.7%
1,421,726
+3.8%
0.00%0.0%
Q4 2021$188,673,000
-1.4%
1,369,091
-0.6%
0.00%
-20.0%
Q3 2021$191,414,000
+49.2%
1,377,981
+4.3%
0.01%
+66.7%
Q2 2021$128,268,000
+47.4%
1,321,270
+3.8%
0.00%
+50.0%
Q1 2021$87,002,000
-11.6%
1,272,896
+10.9%
0.00%
-33.3%
Q4 2020$98,417,000
+44.1%
1,148,241
+9.3%
0.00%
+50.0%
Q3 2020$68,294,000
-37.9%
1,050,502
-30.2%
0.00%
-50.0%
Q2 2020$110,015,000
+131.8%
1,504,787
+7.9%
0.00%
+100.0%
Q1 2020$47,455,000
-13.8%
1,394,516
+38.0%
0.00%0.0%
Q4 2019$55,033,000
+47.8%
1,010,884
+13.3%
0.00%
+100.0%
Q3 2019$37,223,000
-26.4%
892,245
-22.7%
0.00%
-50.0%
Q2 2019$50,545,000
+14.2%
1,154,257
+34.2%
0.00%0.0%
Q1 2019$44,272,000
+79.2%
860,159
+28.7%
0.00%
+100.0%
Q4 2018$24,711,000
+22.7%
668,236
+24.6%
0.00%0.0%
Q3 2018$20,146,000
-1.2%
536,511
+4.0%
0.00%0.0%
Q2 2018$20,382,000
+175.7%
515,726
+79.7%
0.00%
Q1 2018$7,392,000
+46.9%
286,950
+53.9%
0.00%
Q4 2017$5,031,000
-0.9%
186,463
+37.3%
0.00%
Q3 2017$5,078,000
+58.6%
135,848
+6.0%
0.00%
Q2 2017$3,202,000128,1020.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders